Chris Woods

Company: Seagen

Job title: Scientist, Analytical Development

Seminars:

Development & Implementation of an SEC Method for Streamlined Analysis of Free Drug Related Impurities in Novel ADC Chemotypes 9:00 am

• Performing a FDRI analysis is critical for ensuring ADC product safety • Exploring how new ADC chemotypes can pose challenges with respect to FDRI method development, and may not be a good fit for platform methods • Assessing a new SEC method that has been developed to overcomes challenges of the previous RP method…Read more

day: Day Two